Tag: Prescription Drugs
Suspected Pharmacologic Triggers Do Not Appear to Cause Microscopic Colitis
No evidence of causal relationship seen between previously suspected medications and risk for microscopic colitis
Review Compares Efficacy, Safety of Treatments for Hidradenitis Suppurativa
Differences between adalimumab and other targeted treatments mainly not significant
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants
ADHD Medications Remain Linked to Lower Risk for Real-World Adverse Outcomes
Magnitude of these associations decreases alongside increasing prescription rates
Obesity Linked to Financial Hardship, Food Insecurity
People with obesity also reported greater cost-related medication nonadherence than those with overweight, normal weight
Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
Decrease seen in mean monthly headache days and reduction in Migraine Disability Assessment scores
ADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2...
Rate of combined clinically significant or severe hypoglycemia significantly lower with efsitora versus glargine
Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction
Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes
All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
Sustained reduction seen in body weight versus placebo for adults aged 18 to 75 with overweight or obesity, without diabetes
